What Fueled The Previous Growth In The Implantable Cardiac Devices Market?
The implantable cardiac devices market has seen considerable growth due to a variety of factors.
• In recent times, the market size for implantable cardiac devices has witnessed considerable growth. This market will see an upswing from $12.34 billion in 2024 to $13.46 billion in 2025, expanding at a compound annual growth rate (CAGR) of 9.1%.
The historical growth phase can be credited to advancements in the medical sector, an upward trend in cardiovascular diseases, an enlarging elderly population, enhanced reliability and lifespan of devices, increasing mindfulness, and early detection of heart-related issues.
What Is The Expected Growth In The Implantable Cardiac Devices Market Size Evolve over the Forecast Period?
The implantable cardiac devices market is expected to maintain its strong growth trajectory in upcoming years.
• The market for implantable cardiac devices is projected to experience substantial expansion in the upcoming years, with an expectation to reach $18.81 billion by 2029, propelled by a compound annual growth rate (CAGR) of 8.7%.
The predicted growth can be credited to several factors such as advancements in device technology, a surge in preference for minimally invasive procedures, an aging population, increased healthcare spending, and the development of healthcare infrastructure in emerging economies. Key trends shaping the forecast period involve the incorporation of digital health and remote patient monitoring, production of advanced devices with improved features, the rise in customized and patient-oriented cardiac solutions, concentration on cost-effectiveness and value-centric healthcare, a growing trend towards preventive cardiology, and early intervention.
What Main Forces Are Fueling Expansion In The Implantable Cardiac Devices Market?
Expectations for the implantable cardiac devices market's expansion have heightened due to the increasing number of heart disease cases. These escalating figures are linked to numerous risk factors including unhealthy diets, inactive lifestyles, obesity issues, and chronic conditions such as diabetes and hypertension. This problem is further compounded by the aging population and surges in stress levels, leading to more cases of cardiovascular conditions. Implantable cardiac devices come into play in managing and treating conditions like heart failure, arrhythmias, and coronary artery diseases. This growing patient population necessitates the need for innovation and investment in the creation of better cardiac devices to improve treatment results. For example, the Singapore Heart Foundation (SHF), a non-profit organization in Singapore, reported that ischemic heart disease accounted for 5,302 deaths in May 2024, marking a minor rise from 5,290 deaths in 2022. As such, the implantable cardiac devices market has seen steady growth influenced by the increased prevalence of heart disease.
What Are The Primary Segments In The Global Implantable Cardiac Devices Market?
The implantable cardiac devicesmarket covered in this report is segmented –
1) By Type: Pacemaker, Implantable Cardioverter Defibrillator (ICD), Biventricular Implantable Cardioverter Defibrillator (BI-V ICD)
2) By Application: Bradycardia, Tachycardia, Heart Failure, Other Applications
3) By End User: Hospitals, Specialty Clinics, Other End Users
Subsegments:
1) By Pacemaker: Single-Chamber Pacemakers, Dual-Chamber Pacemakers, Rate-Responsive Pacemakers
2) By Implantable Cardioverter Defibrillator (ICD): Transvenous ICDs, Subcutaneous ICDs, Wearable Cardioverter Defibrillators
3) By Biventricular Implantable Cardioverter Defibrillator (BI-V ICD): Standard BI-V ICDs, Advanced BI-V ICDs with Cardiac Resynchronization Therapy (CRT)
Pre-Book The Implantable Cardiac Devices Global Market Report 2025 Report For Swift Delivery And Comprehensive Insights:
What Trends Are Shaping The Implantable Cardiac Devices Market?
Prominent firms in the implantable cardiac devices market prioritize improving compatibility with diagnostic instruments such as AutoMRI, in order to prolong device lifespan and enhance patient safety. The AutoMRI feature in implantable cardiac defibrillators automatically modifies the device configurations to guarantee its safe usage during MRI scans, thereby improving patient care and facilitating access to sophisticated imaging technology. For instance, MicroPort CRM, a medical device company headquartered in France, debuted the ULYS implantable cardioverter defibrillator (ICD) and INVICTA defibrillation leads in Japan, in October 2023. These products offer superior technology with low current utilization, thereby enhancing device longevity and MRI compatibility. The ULYS ICD is fitted with the PARAD+ arrhythmia discrimination algorithm and AutoMRI capability; while the INVICTA lead provides accurate pacing and defibrillation treatment, reflecting a 100% success rate in implantation and 97.4% complication-free rate in clinical experiments.
Who Are the Key Players In The Implantable Cardiac Devices Market?
Major companies operating in the implantable cardiac devices market are:
• Johnson & Johnson
• Abbott Laboratories
• Medtronic plc
• Koninklijke Philips N.V.
• Stryker Corporation
• Boston Scientific Corporation
• B. Braun Melsungen AG
• Edwards Lifesciences Corporation
• Biotronik SE & Co. KG
• Zoll Medical Corporation
• Nihon Kohden Corporation
• LivaNova plc
• Lepu Medical Technology
• MicroPort Scientific Corporation
• AtriCure Inc.
• LifeTech Scientific Corporation
• Berlin Heart GmbH
• EBR Systems Inc.
• Defibtech LLC
• CVRx Inc.
• Progetti Srl
• Endotronix Inc.
• Jarvik Heart Inc.
• Xeltis AG
• Carmat SA
• Windmill Cardiovascular Systems Inc
What Is The Most Dominant Region In The Implantable Cardiac Devices Market?
North America was the largest region in the implantable cardiac devices market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the implantable cardiac devices market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
